© 2020 MJH Life Sciences and HCPLive. All rights reserved.
August 13, 2020
An expert discusses how a registry of gastrointestinal symptoms is leading research during COVID-19.
According to new findings, low Glx response is associated with increase in clinical improvements in at-need patients.
A gastroenterologist discusses some of the findings regarding COVID-19 and gastrointestinal symptoms.
August 12, 2020
Less than 1% of nearly 500,000 hospitalized patients required kidney replacement therapy.
Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.
REGENXBIO also announced the scheduling of a phase 2 trial testing RGX-314 for wet AMD.
August 11, 2020
Patients with IPF and multiple comorbidities experienced similar effects from nintedanib to those with few or no comorbidities.
In a cross-sectional study among CAD patients, investigators found that 30.3% of heart team treatment recommendations diverged from original consultation.
David Ho, MD, likens and contrasts the pandemic to 3 other viral outbreaks and their respective responses.
August 10, 2020
A team of researchers have added 3 new modifiable risk factors to a list of 9 known factors that increase the risk of developing dementia.